US Pharma Turns to China for Drug Innovation Amid Rising Competition
Key Points A little-known biotech company, Summit Therapeutics, shocked the biopharmaceutical industry last year when it announced its experimental cancer drug outperformed Merck’s blockbuster Keytruda
